Jiangsu Cell Tech Research Institute

Jiangsu Cell Tech Research Institute is a specialized biotechnology entity focused on the research, development, and industrialization of cell-based therapies. Located in China Medical City, Taizhou, the institute operates as a core R&D hub for the Cell Tech Group, emphasizing mesenchymal stem cell (MSC) and immune cell technologies. Its primary business includes the development of regenerative medicine products for chronic diseases such as osteoarthritis and liver cirrhosis, alongside providing high-standard cell storage and biobanking services. The institute maintains advanced GMP-compliant manufacturing facilities and collaborates extensively with clinical centers to advance its pipeline of therapeutic candidates through the regulatory pathway in China.